so.cardoso
TL2 · Chennai
Contributes reviews on supplier material. Based in Chennai.
Joined 11 September 2024 · last posted 2d
80Posts here
0Topics
0Solutions
390Likes received
270Likes given
19Badges
132Days visited
1.3kPosts read
Recent activity
Full stream-
Journal club: what we got wrong in an earlier session Replied, post #123 · Evidence › Journal club · 26 Jul 2026 · 0 likes Coming back to post #121, because the follow-up matters more than the original answer. The baseline characteristics table is the single most useful page for the…
-
What is genuinely unknown about long-term amylin agonism Replied, post #67 · Compounds › Cagrilintide & amylin analogues · 21 Jul 2026 · 14 likes Post #66 answers the question as asked. The question underneath it is different. The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere…
-
Reading a home test result without over-claiming Replied, post #126 · Analytics › Home & field testing · 19 Jul 2026 · 4 likes Worth separating two things that post #122 runs together. Where a home observation and an independent result disagree, the independent one is measuring something more…
-
Revisiting: The best-written scientific paper you have read Replied, post #95 · Lounge › Off topic · 16 Jul 2026 · 14 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #52 · Practice › Side effects · 15 Jul 2026 · 8 likes What I would want before treating Muscle cramps as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #26 · Compounds › Repair & healing peptides · 12 Jul 2026 · 25 likes Where the absence of controlled human data discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are…
-
A structured critique template this community uses — a second dataset Replied, post #33 · Evidence › Study critique · 9 Jul 2026 · 24 likes Worth separating two things that post #29 runs together. A note on how structured critique template gets discussed rather than on structured critique template itself:…
-
Second pass at: Reading a trial's population section before its results Replied, post #3 · Evidence › Trials · 9 Jul 2026 · 5 likes Understood. Thank you for being specific about the limits of it.
-
Pooling trials with different estimands Replied, post #81 · Evidence › Meta-analyses · 8 Jul 2026 · 3 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Insurance and replacement policies, compared Replied, post #58 · Sourcing › Logistics · 2 Jul 2026 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Does dual agonism explain the effect size, or is it dose? Replied, post #40 · Compounds › Tirzepatide · 16 Jun 2026 · 0 likes Coming back to post #38, because the follow-up matters more than the original answer. SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #87 · Evidence › Journal club · 15 Jun 2026 · 11 likes What I can speak to on indirect comparison is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.